Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017.

Authors :: Albertsson-Lindblad A
Palsdottir T
Smedby KE
Weibull CE
Glimelius I
Jerkeman M
Source :: Haematologica [Haematologica] 2022 Mar 01; Vol. 107 (3), pp. 740-743. Date of Electronic Publication: 2022 Mar 01.
Publication Year :: 2022

Subjects :: Adult
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bendamustine Hydrochloride administration & dosage
Bendamustine Hydrochloride therapeutic use
Cyclophosphamide administration & dosage
Doxorubicin administration & dosage
Humans
Prednisone administration & dosage
Rituximab administration & dosage
Sweden epidemiology
Vincristine administration & dosage
Lymphoma, Mantle-Cell diagnosis
Lymphoma, Mantle-Cell drug therapy
Lymphoma, Mantle-Cell epidemiology

Full Text Access

Tools